Kai Lin Liu
Directeur en chef des Investissements chez Beijing Biostar Pharmaceuticals Co. Ltd.
Postes actifs de Kai Lin Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Directeur en chef des Investissements | 01/07/2020 | - |
| Secrétaire Général | 01/09/2020 | - | |
| Investor Relations Contact | - | - |
Historique de carrière de Kai Lin Liu
Formation de Kai Lin Liu
| Nankai University | Graduate Degree |
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Graduate Degree | 1 |
| Chief Investment Officer | 1 |
| Investor Relations Contact | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Bourse
- Insiders
- Kai Lin Liu
- Expérience
